...reapening the benefits of robust expansion in export markets.
Zentiva, one of central Europe's biggest pharmaceutical firms, reported net profit of 2.20 billion crowns ($102.9 million), above an average forecast of 2.15 billion crowns in a Reuters poll of eleven analysts.
The company, partly owned by France's Sanofi-Aventis , also announced the acquisition of 75 percent of Turkish Eczacibasi Generic Pharmaceuticals from EIS Eczacibasi Ilac Sanayi for 460 million euros in cash.